ABVC Biopharma Company Insiders
| ABVC Stock | USD 3.35 0.23 6.42% |
ABVC Biopharma employs about 16 people. The company is managed by 7 executives with a total tenure of roughly 38 years, averaging almost 5.0 years of service per executive, having 2.29 employees per reported executive. Evaluation of ABVC Biopharma's management performance can provide insight into the firm performance.
ABVC Biopharma Management Team Effectiveness
The company has return on total asset (ROA) of (0.1091) % which means that it has lost $0.1091 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4242) %, meaning that it created substantial loss on money invested by shareholders. ABVC Biopharma's management efficiency ratios could be used to measure how well ABVC Biopharma manages its routine affairs as well as how well it operates its assets and liabilities.ABVC Biopharma Workforce Comparison
ABVC Biopharma is rated second in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 105. ABVC Biopharma retains roughly 16.0 in number of employees claiming about 15% of equities under Health Care industry.
ABVC Biopharma Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific ABVC Biopharma insiders, such as employees or executives, is commonly permitted as long as it does not rely on ABVC Biopharma's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, ABVC Biopharma insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
ABVC Biopharma Notable Stakeholders
An ABVC Biopharma stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as ABVC Biopharma often face trade-offs trying to please all of them. ABVC Biopharma's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting ABVC Biopharma's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| TsungShann EMBA | Chief Director | Profile | |
| TsungShann Jiang | Member Officer | Profile | |
| Leeds Chow | Chief Officer | Profile | |
| Howard MD | Pres CEO | Profile | |
| ChiHsin King | Chief Officer | Profile | |
| Uttam Patil | Chief Officer | Profile | |
| Eugene Jiang | Chairman Officer | Profile |
About ABVC Biopharma Management Performance
The success or failure of an entity such as ABVC Biopharma often depends on how effective the management is. ABVC Biopharma management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of ABVC management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the ABVC management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. ABVC BioPharma, Inc. is a subsidiary of YuanGene Corporation. Abvc Biopharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 28 people.
Please note, the presentation of ABVC Biopharma's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, ABVC Biopharma's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of ABVC Biopharma's management manipulating its earnings.
ABVC Biopharma Workforce Analysis
Traditionally, organizations such as ABVC Biopharma use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare ABVC Biopharma within its industry.ABVC Biopharma Manpower Efficiency
Return on ABVC Biopharma Manpower
| Revenue Per Employee | 31.8K | |
| Revenue Per Executive | 72.8K | |
| Net Loss Per Employee | 328.7K | |
| Net Loss Per Executive | 751.3K |
Complementary Tools for ABVC Stock analysis
When running ABVC Biopharma's price analysis, check to measure ABVC Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ABVC Biopharma is operating at the current time. Most of ABVC Biopharma's value examination focuses on studying past and present price action to predict the probability of ABVC Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ABVC Biopharma's price. Additionally, you may evaluate how the addition of ABVC Biopharma to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |